Drug Shortage Report for TEVA-LOSARTAN

Last updated on 2020-08-21 History
Report ID 88189
Drug Identification Number 02357976
Brand name TEVA-LOSARTAN
Common or Proper name LOSARTAN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LOSARTAN POTASSIUM
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-07-02
Estimated end date 2020-09-30
Actual end date 2020-08-20
Shortage status Resolved
Updated date 2020-08-21
Company comments Allocating to 100% of our market.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v30 2020-08-21 English Compare
v29 2020-08-20 French Compare
v28 2020-08-20 English Compare
v27 2020-07-30 French Compare
v26 2020-07-30 English Compare
v25 2020-07-16 French Compare
v24 2020-07-16 English Compare
v23 2020-05-14 French Compare
v22 2020-05-14 English Compare
v21 2020-05-08 French Compare
v20 2020-05-08 English Compare
v19 2020-04-09 French Compare
v18 2020-04-09 English Compare
v17 2020-03-26 French Compare
v16 2020-03-26 English Compare
v15 2020-02-13 French Compare
v14 2020-02-13 English Compare
v13 2020-01-17 French Compare
v12 2020-01-17 English Compare
v11 2019-12-19 French Compare

Showing 1 to 20 of 30